Genzyme, Viacell in deal to develop diabetes therapy

03/16/2005 | Boston Globe (tiered subscription model), The

Genzyme and Viacell have signed a deal to jointly develop a treatment for juvenile diabetes, with Genzyme paying the costs of development until the therapy is ready for human clinical trials. Viacell's research involves the use of pancreatic tissue from cadavers to produce islet cells that can be introduced into a patient's liver to begin producing insulin.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA